 |
Antisense oligonucleotide targeting theUSH2Agene |
|---|---|
| Trade Name | |
| Orphan Indication | Retinitis pigmentosa |
| EU Market Approval | EU |
| EU Designation Date | 2017-03-20 00:00:00 |
| Sponsor | ProQR Therapeutics IV BV |
Related Access Program
| |
Antisense oligonucleotide targeting theUSH2Agene |
|---|---|
| Trade Name | |
| Orphan Indication | Retinitis pigmentosa |
| EU Market Approval | EU |
| EU Designation Date | 2017-03-20 00:00:00 |
| Sponsor | ProQR Therapeutics IV BV |